BrainAurora Medical Technology Limited submitted its Monthly Return for Equity Issuer for the period ending 30 June 2026, confirming stability across all share-capital metrics.

Authorised and Registered Capital • Authorised share count held steady at 500.00 billion ordinary shares, each with a par value of USD 0.0000001, leaving authorised share capital unchanged at USD 50,000.

Issued Share Capital • Issued ordinary shares (excluding treasury shares) stayed at 1.36 billion, with no treasury shares outstanding. • No new shares were issued, repurchased, cancelled or converted during the month, resulting in a constant total issued share base of 1.36 billion shares.

Capital-Raising Instruments • The company reported no movements under share-option schemes, warrants, convertible securities or any other equity-related agreements.

Public Float Status • BrainAurora confirmed compliance with the Hong Kong Main Board’s minimum public-float requirement of 25%.

Administrative Details • The filing covers activity through 30 June 2026 and was lodged with Hong Kong Exchanges and Clearing Limited on 06 July 2026. • The declaration was signed by Director Tan Zheng.

With no alterations to authorised or issued capital and full adherence to public-float rules, BrainAurora’s equity structure remained unchanged throughout June 2026.